Literature DB >> 30395798

Fosfomycin as a promising alternative to treat urinary tract infection due to multidrug resistant uropathogens.

Drisya Udayan1, Sadia Khan1, Unnimaya Pullanhi1, Anil Kumar1.   

Abstract

Entities:  

Year:  2018        PMID： 30395798      PMCID： PMC6179736          DOI： 10.5152/tud.2018.55889

Source DB:  PubMed          Journal:  Turk J Urol        ISSN： 2149-3235


× No keyword cloud information.
  4 in total

1.  Fosfomycin Susceptibility in Urinary Tract Enterobacteriaceae.

Authors:  Bhargav Patel; Kinjal Patel; Anjali Shetty; Rajeev Soman; Camilla Rodrigues
Journal:  J Assoc Physicians India       Date:  2017-09

2.  Fosfomycin susceptibility among multidrug-resistant, extended-spectrum beta-lactamase-producing, carbapenem-resistant uropathogens.

Authors:  Sayantan Banerjee; Mallika Sengupta; Tanoy Kumer Sarker
Journal:  Indian J Urol       Date:  2017 Apr-Jun

3.  Nitrofurantoin and Fosfomycin for Extended Spectrum Beta-lactamases Producing Escherichia coli and Klebsiella pneumoniae.

Authors:  Neeraj Kumar Tulara
Journal:  J Glob Infect Dis       Date:  2018 Jan-Mar

4.  Trend analysis of bacterial uropathogens and their susceptibility pattern: A 4-year (2013-2016) study from Aseer region, Saudi Arabia.

Authors:  Abdulaziz Alamri; Mohamed E Hamid; Muhammad Abid; Abdulrahman M Alwahhabi; Khalid M Alqahtani; Mohammed S Alqarni; Mosleh Abomughaid
Journal:  Urol Ann       Date:  2018 Jan-Mar
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.